Skip to content
10-K

Annual Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-21-001627

← back to feed
Filed
Jul 22, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Dec 31, 2019 100M sh
Operating Cash Flow FY 2019 · Dec 31, 2018 $4
Current Liabilities FY 2019 · Dec 31, 2018 $198.88K
Total Liabilities FY 2019 · Dec 31, 2018 $198.88K
Current Assets FY 2019 · Dec 31, 2018 $2.12K
Total Assets FY 2019 · Dec 31, 2018 $2.12K
Sga Expense FY 2019 · Dec 31, 2018 $92.53K
Net Income FY 2019 · Dec 31, 2018 −$92.52K
Operating Income FY 2019 · Dec 31, 2018 −$92.53K
Cash And Equivalents FY 2019 · Dec 31, 2017 $1.19K
Stockholders Equity FY 2019 · Dec 31, 2017 −$104.24K